Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thx for that article carp, looks good. Indeed, you never know, promising tech for cheap, can't argue with that.
Don't really recall, do the big boys fish this deep down in the pond too?
Would be a sweet pay day.
AGN buying MAPP
More M&A expected in bio land this year, worth keeping in mind.
http://dealbook.nytimes.com/2013/01/22/allergan-to-buy-map-pharmaceuticals-for-958-million/?smid=tw-share
Very comprehensive, Sam, thx. Does seem like this could become a success story like say JAZZ.
Technically, the 5.18 from 12/12 seems to be acting as support now, which is a good sign. Would love for it to retest that previous high.
Bit of confusion on when earnings will be: some say today, others tomorrow. Will be very interesting.
Research in Motion upgraded to Outperform from Sector Perform at Scotia Capital
The pre-unveiling pump is running on full engine.
Ampio announces active IND for Optina for treatment of DME
Ampio Pharmaceuticals announced that the FDA has accepted the company's IND for Optina for the treatment of Diabetic Macular Edema, or DME. Ampio plans to commence enrollment in a clinical trial in Q1. The FDA granted Optina 505 b 2 status in July, 2012. Drugs designated under this pathway can be approved on a single trial.
A clear example of resistance just not letting up. Does look like a quick return to $8 is nearing.
Indeed, have those two on watch.
SNDK reports tomorrow, SYNA on the 24th. Let's see if the push lasts short-term.
A crowded space, especially with Samsung pushing hard.
They've said they'll make sure there'll be enough apps to satisfy the user appetite. Will be quintessential, having enough critical mass to ensure developers also design for the BB platform.
Next Wednesday we get the official unveiling, the run into it should be fun.
Really interested in the first sales figures; see if they really can make a comeback.
RIMM upgraded to Buy from Hold at Jefferies
Up nicely in PM
Jefferies upgraded Research in Motion to Buy and raised its price target for shares to $19.50 from $13 on expectations the phone maker will enable Blackberry email on iPhones and Android devices. Jefferies believes this change is unknown by investors and will lead drive upside to RIM's May and August quarter results.
Hi fink, we only do big board plays here, thanks for understanding.
Using the 20/50/100/200MA on both the daily and weekly chart. I rarely look at the monthly.
Only other thing I look for on those charts are things like double bottom/top. An example of a stock I've posted on StockTwits is M: it has a DB @ 36.35 and for that, you need the daily (sometimes weekly).
Most of my S/R lines are drawn on the basis of the 2M/3M/5M/15M/30M charts. Since the intra-day range is usually narrow for any given stock, the S/R lines I see drawn on the 2M chart (my main chart) are enough for trading. I then look at the 3M/5M chart for volume hints and occasionally 'hidden' S/R points, and the 15M/30M to identify he bigger S/R lines as well as gap ups/downs.
I've included a screenshot of my NFLX 2M chart. Orange is strong R, dark blue is strong S. Obviously, it doesn't always work out.
A boatload of factors, Sam:
- Time of the week
- Option price movement gaps: say one strike price is liquid and goes from .75 to .80 to .85 and the other goes from 0.145 to 0.30 to 0.40, I'd be more inclined to get 5 x .80 than 10 x .40 (or even 10 x .80, if I'm feeling confident I can get out with just the minor loss)
- Factor of gambling: do I play safe and go ITM/ATM or take a bigger risk far OTM?
- Lack of the proper strike price: sometimes the next strike price is $5 away and there's no way it'll hit so you got no choice but to go for the more expensive ITM strike price.
I tend to go for that strike price which has lower option prices attached to it, in as far as that's possible: .20 to .40 usually works out pretty fine.
Rest is a bit of intuition: TBH, I look at volatility way too little. Only thing I care about is the S/R lines on my chart.
Wow, he deserves my respect simply for that long article. Will have to give it a read tomorrow.
Very heated debate about this stock, but as I've said before, this buying ain't just retail.
Anyone watching CLSN? Quite the raid lol.
Only if there's panic, though I think we had bit of that last time. A 15% drop from this level would hurt.
No worries.
Seeing the natural pull-back now, but it's good to know big money has not forgotten about this one. Will keep on strong watch.
Another upgrade today, buying puts in this markets means being sure the company is half kaput. In almost all other cases you're killed. :(
And yes, better to lose a bit of proit by waiting longer for confirmation.
Agree on the apps front, HW alone does not cut it nowadays.
Pull-backs in this market are pretty rare, but it did drop 80c+ yesterday before bouncing back, so things can go quikly.
RIMM event to be held 1/30
Plenty can happen in two weeks, as with earnings the swings should become more pronounced (well, perhaps not as much as last Friday ;))
Multiple airlines saying they're not taking any action, and the stock's been rebounding a bit in PM.
Of course, the media microscope isn't helping. For now, trader's paradise IMO.
ITMN upgraded to Buy from Neutral at UBS
Took a bit of guts to hold after the offering, but in typical WS style, it's higher than it was before the offering.
UBS believes InterMune's (ITMN) ASCEND study for its IPF drug has a greater probability of success vs. Biogen Idec's (BIIB) BIBF1120 competing drug and that management has lowered EU expectations enough that investors will see a value opportunity into the data. Price target raised to $15 from $9.
Boeing down 5% after Air Nippon has smoke problem with dreamliner and grounds its entire fleet
The saga continues.
Looks like the hawks showed they're there in the FOMC minutes, but that's it for now.
Then there's still the race to debase around the globe.
Lol, nice. My first encounter with it ;)
Lol binks, wth is that?
BOSC seems to be taking the stairs this time, and CBMX bounced over the 50MA. Positive movement.